0000000001303519

AUTHOR

Sami Kortet

showing 10 related works from this author

Structure-Activity Relationship Analysis of 3-Phenylcoumarin-Based Monoamine Oxidase B Inhibitors

2018

Monoamine oxidase B (MAO-B) catalyzes deamination of monoamines such as neurotransmitters dopamine and norepinephrine. Accordingly, small-molecule MAO-B inhibitors potentially alleviate the symptoms of dopamine-linked neuropathologies such as depression or Parkinson's disease. Coumarin with a functionalized 3-phenyl ring system is a promising scaffold for building potent MAO-B inhibitors. Here, a vast set of 3-phenylcoumarin derivatives was designed using virtual combinatorial chemistry or rationally de novo and synthesized using microwave chemistry. The derivatives inhibited the MAO-B at 100 nM−1 μM. The IC50 value of the most potent derivative 1 was 56 nM. A docking-based structure-activi…

0301 basic medicineentsyymitParkinson's diseaseParkinsonin tautita311101 natural scienceslääkesuunnittelumonoamine oxidase B (MAO-B)lcsh:Chemistry03 medical and health scienceschemistry.chemical_compoundstructure-activity relationship (SAR)Dopamine3-phenylcoumarinmedicineStructure–activity relationshipoksidoreduktaasitkumariinitta116ta317inhibiittoritOriginal Researchchemistry.chemical_classificationbiologyvirtual drug designta1182General ChemistryCoumarin3. Good health0104 chemical sciences010404 medicinal & biomolecular chemistryChemistry030104 developmental biologyMonoamine neurotransmitterEnzymeBiochemistrychemistrylcsh:QD1-999Docking (molecular)biology.proteinParkinson’s diseaseMonoamine oxidase BMonoamine oxidase Amedicine.drugFrontiers in Chemistry
researchProduct

Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives

2018

A comprehensive set of 3-phenylcoumarin analogues with polar substituents was synthesised for blocking oestradiol synthesis by 17-b-hydroxysteroid dehydrogenase 1 (HSD1) in the latter part of the sulphatase pathway. Five analogues produced 62% HSD1 inhibition at 5 mM and, furthermore, three of them produced 68% inhibition at 1 mM. A docking-based structure-activity relationship analysis was done to determine the molecular basis of the inhibition and the cross-reactivity of the analogues was tested against oestrogen receptor, aromatase, cytochrome P450 1A2, and monoamine oxidases. Most of the analogues are only modestly active with 17-b-hydroxysteroid dehydrogenase 2 – a requirement for lowe…

0301 basic medicinearomatase17-Hydroxysteroid Dehydrogenasesmedicine.drug_classStereochemistry3-imidazolecoumarinaromataasiDehydrogenaseta3111LigandsStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compoundstructure-activity relationship (SAR)0302 clinical medicineCoumarinsIn vivo17-β-hydroxysteroid dehydrogenase 1 (HSD1)Drug DiscoverymedicineHumansMoietyEnzyme InhibitorsAromatasePharmacologyAromatase inhibitorDose-Response Relationship DrugEstradiolMolecular StructurebiologyChemistrylcsh:RM1-950CYP1A2ta1182General MedicineCoumarin3. Good healthMolecular Docking Simulationlcsh:Therapeutics. Pharmacology030104 developmental biologyDocking (molecular)030220 oncology & carcinogenesisbiology.proteinComputer-Aided Design3-Phenylcoumarinhormones hormone substitutes and hormone antagonistsResearch PaperJournal of Enzyme Inhibition and Medicinal Chemistry
researchProduct

Enzymatic Resolution of 3-oxodicyclopentadiene on a Decagram Scale

2018

The chiral building block 3-oxodicyclopentadiene (1) can be readily resolved on a decagram scale by a short sequence consisting of (1) reduction to the corresponding endo-alcohol, (2) enzymatic oxidative resolution with a ketoreductase enzyme to give (+)-1 and the (+)-form of the endo-alcohol, and (3) reoxidation of the (+)-endo-alcohol with another ketoreductase to give (–)-1. With a selectivity factor of 310, the enantiomeric ratios of the resolved (+)-endo-alcohol and (+)-ketone are both >99:1. Both enzymatic oxidations could be performed with a at least 300:1 substrate/catalyst ratio (w/w).

chemistry.chemical_classificationentsyymithapetustetrahydromethanoindenoneResolution (mass spectrometry)alkoholit (yhdisteet)ChemistryStereochemistryoxidationOrganic ChemistrySubstrate (chemistry)resolutionAlcoholCatalysisalcoholsgram-scale synthesischemistry.chemical_compoundEnzymeEnantiomerSelectivity
researchProduct

Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10

2018

Intestinal and hepatic glucuronidation by the UDP-glucuronosyltransferases (UGTs) greatly affect the bioavailability of phenolic compounds. UGT1A10 catalyzes glucuronidation reactions in the intestine, but not in the liver. Here, our aim was to develop selective, fluorescent substrates to easily elucidate UGT1A10 function. To this end, homology models were constructed and used to design new substrates, and subsequently, six novel C3-substituted (4-fluorophenyl, 4-hydroxyphenyl, 4-methoxyphenyl, 4-(dimethylamino)phenyl, 4-methylphenyl, or triazole) 7-hydroxycoumarin derivatives were synthesized from inexpensive starting materials. All tested compounds could be glucuronidated to nonfluorescen…

0301 basic medicineMutantGlucuronidationPharmaceutical ScienceUGT1A10030226 pharmacology & pharmacySubstrate Specificity7-hydroxycoumarin derivativechemistry.chemical_compound0302 clinical medicineDrug DiscoveryCRYSTAL-STRUCTUREGlucuronosyltransferaseta116ta317AFFINITYchemistry.chemical_classificationChemistry3. Good healthMolecular ImagingMolecular Docking Simulation7-hydroxycoumarin317 Pharmacyin silicoMolecular MedicinefluorescenceUDP-glucuronosyltransferaseEXPRESSIONENZYMEStereochemistryIn silicoKineticsFLUORESCENT-PROBETriazoleta311103 medical and health sciencesGlucuronidesMicrosomesXENOBIOTICSHumansUmbelliferonesFluorescent DyesGLUCURONIDATIONta1182glucuronidationfluoresenssiSubstrate (chemistry)drug metabolism030104 developmental biologyEnzymeDRUG-METABOLISMDrug DesignMolecular ProbesMutationMutagenesis Site-DirectedORAL BIOAVAILABILITYDrug metabolism
researchProduct

Catalytic Enantioselective Total Synthesis of (+)-Lycoperdic Acid.

2020

A concise enantio- and stereocontrolled synthesis of (+)-lycoperdic acid is presented. The stereochemical control is based on iminium-catalyzed Mukaiyama–Michael reaction and enamine-catalyzed organocatalytic α-chlorination steps. The amino group was introduced by azide displacement, affording the final stereochemistry of (+)-lycoperdic acid. Penultimate hydrogenation and hydrolysis afforded pure (+)-lycoperdic acid in seven steps from a known silyloxyfuran. peerReviewed

Stereochemistryaminohapot010402 general chemistry01 natural sciencesBiochemistryCatalysisCatalysisHydrolysischemistry.chemical_compoundLactonesLycoperdic acidPhysical and Theoretical ChemistryComputingMilieux_MISCELLANEOUSkemiallinen synteesiMolecular Structure010405 organic chemistryChemistry[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic ChemistryEnantioselective synthesisTotal synthesisStereoisomerism0104 chemical scienceskatalyysiAzideIminesOrganic letters
researchProduct

CCDC 1827648: Experimental Crystal Structure Determination

2018

Related Article: Katja Kärki, Juha H. Siitonen, Mona Cederström, Sami Kortet, Petri M. Pihko|2018|Synlett|29|1723|doi:10.1055/s-0037-1610109

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(-)-3a477a-tetrahydro-1H-47-methanoinden-1-oneExperimental 3D Coordinates
researchProduct

CCDC 1831369: Experimental Crystal Structure Determination

2018

Related Article: Katja Kärki, Juha H. Siitonen, Mona Cederström, Sami Kortet, Petri M. Pihko|2018|Synlett|29|1723|doi:10.1055/s-0037-1610109

Space GroupCrystallography(-)-exo-3a477a-tetrahydro-1H-47-methanoinden-1-olCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1972521: Experimental Crystal Structure Determination

2020

Related Article: Sami Kortet, Aurélie Claraz, Petri M. Pihko|2020|Org.Lett.|22|3010|doi:10.1021/acs.orglett.0c00772

Space GroupCrystallography(2R5R)-25-bis(35-bis(trifluoromethyl)phenyl)pyrrolidineCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1827649: Experimental Crystal Structure Determination

2018

Related Article: Katja Kärki, Juha H. Siitonen, Mona Cederström, Sami Kortet, Petri M. Pihko|2018|Synlett|29|1723|doi:10.1055/s-0037-1610109

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameters(+)-3a477a-tetrahydro-1H-47-methanoinden-1-oneExperimental 3D Coordinates
researchProduct

CCDC 1827647: Experimental Crystal Structure Determination

2018

Related Article: Katja Kärki, Juha H. Siitonen, Mona Cederström, Sami Kortet, Petri M. Pihko|2018|Synlett|29|1723|doi:10.1055/s-0037-1610109

Space GroupCrystallographyCrystal SystemCrystal Structurerac-endo-3a477a-tetrahydro-1H-47-methanoinden-1-olCell ParametersExperimental 3D Coordinates
researchProduct